Skip Navigation


European Heart Journal Advance Access originally published online on February 15, 2005
European Heart Journal 2005 26(6):623-624; doi:10.1093/eurheartj/ehi134
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/6/623-a    most recent
ehi134v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bartnik, M.
Right arrow Articles by Rydén, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bartnik, M.
Right arrow Articles by Rydén, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

 

Oral glucose tolerance test or metabolic syndrome criteria to predict risk in patients with coronary heart disease?: reply

Malgorzata Bartnik

Department of Cardiology
Karolinska University Hospital Solne
17176 Stockholm, Sweden
Tel: +46 8 517 70461
Fax: +46 8 31 10 44
E-mail address: malgorzata.bartnik@medks.ki.se

Lars Rydén

E-mail address: lars.ryden@medks.ki.se

The first 10% of the full text of this article appears below.

We are grateful for your interest in our article and your comments are indeed valid and important. Abnormal glucose metabolism is part of the metabolic syndrome as an optional or necessary component depending on the definition by the US National Cholesterol Education Program (NCEP) Adult Treatment Panel III or . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?